期刊文献+

水飞蓟宾对人舌癌细胞Tca的抑制作用 被引量:5

Inhibition effects of silibinin on human tongue cancer cell line Tca
下载PDF
导出
摘要 目的:研究水飞蓟宾在体外对舌癌细胞的作用,并进一步探讨其可能的作用机制。方法:MTT实验测定水飞蓟宾对舌癌细胞系(Tca)的半数抑制浓度(IC50);平板克隆形成实验检测加药前后细胞的克隆形成能力;流式细胞仪检测加药前后细胞周期的变化。结果:水飞蓟宾对舌癌细胞系有较强的抑制作用,作用48h时,IC50约为100μmol/L;水飞蓟宾作用后,舌癌细胞的平板克隆形成能力降低;流式细胞仪检测结果显示细胞出现G1期阻滞。结论:水飞蓟宾在体外对舌癌细胞具有明显的抑制作用,其作用机制可能是细胞出现G1期阻滞。 Objective:To study the inhibition effects of silibinin on tongue cancer cell line Tca and the possible mechanism. Methods: Tongue cancer cell line Tca was cultured to study the effects of silibinin on cell proliferation. First, MTT assay was used to evaluate the IC50 of silibinin on the cells. Second, through colony formation assay, the celt proliferation ability was detected. At last, distribution of cell cycle was analysed by flow cytometry. Results:Silibinin inhibited the growth of Tca cells. The IC50 was about 100 μmol/L, when the cells were cultured with silibinin in 48 h. Silibinin also inhibited the cells colony formation and caused G1 arrest. Conclusion: Silibinin could inhibit Tca cell proliferation ability, and the possible mechanism might be the cell cycle stopped at G1.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2009年第2期281-284,共4页 Journal of Practical Stomatology
关键词 水飞蓟宾 舌癌 细胞周期 流式细胞术 Silibinin Tongue cancer Cell cycle Flow cytometry
  • 相关文献

参考文献11

  • 1Tyagi A, Agarwal C, Harrison G, et al. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages [ J ]. Carcinogenesis, 2004,25(9) :1711 - 1720.
  • 2Sharma G, Singh RP, Chan DC, et al. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells[ J ]. Anticancer Res, 2003,23 ( 3B ) : 2649 - 2655.
  • 3Agarwal C, Singh RP, Dhanalakshmi S, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells [ J ]. Oncogene, 2003,22 ( 51 ) : 8271 - 8282.
  • 4Zi X, Agarwal R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: hnplications for prostate cancer intervention[ J]. Proc Natl Acad Sci USA, 1999,96(13) :7490 - 7495.
  • 5Zi X, Zhang J, Agarwal R, et al. Silibinin up-regulates insulin- like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells[J]. Cancer Res, 2000,60(20) :5617 -5620.
  • 6Zhao J, Lahiri-Chatterjee M, Sharma Y, et al. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin [ J ]. Carcinogenesis,2000,21(4) :811 -816.
  • 7金洲祥,李永国,朱少俊,王飞海.白藜芦醇对胰腺癌细胞的抑制作用[J].肝胆胰外科杂志,2007,19(6):352-354. 被引量:4
  • 8Manna SK, Mukhopadhyay A, Van NT, et al. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis [ J ].J Immunol, 1999, 163 ( 12 ) :6800 - 6809.
  • 9Zi X, Feyes DK, Agarwal R. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: Induction of Gl arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins [J]. Clin Cancer Res, 1998,4(4) :1055 - 1064.
  • 10Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [ J ]. Biochem Pharmacol, 2000,60 ( 8 ) : 1051 - 1059.

二级参考文献12

  • 1孙定人 张石革 梁之江.中国临床新药集[M].北京:中国医药科技出版社,2001.715-716.
  • 2Wu JZ, Situ ZQ, Chen J,et al. Chemosensitivity of salivarygl and and oral cancer cell lines. Chin Med J, 1992,105(12) :1026.
  • 3Tsai CM, Hsiao SH, Frey CM, et al. Combination cytotoxic effects of cis-diamminedichloroplatinum ( Ⅱ ) and 5-fluorouracil with and without leucovorin against human nonsmall cell lung cancer cell lines. Cancer Res, 1993,53(5):1079.
  • 4Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine : History, current research, and futurre direction. Cancer , 2001,92(6): 1591.
  • 5Kantarjian HM, Talpaz M, Smith TL, et al. Homoharringtonine and low-dose eytarabine in the management of late chronic-phase chronic myelogenous leukemia. J Clin Oncol,2000,18(20) : 3513.
  • 6Atten MJ,Godoy-Romero E,Attar BM,et al. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells [J]. Invest New Drugs, 2005,23(2):111-119.
  • 7Pozo-Guisado E,Merino JM.Mulero-Navarro S,et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-κappa B[J]. Int J Cancer,2005,115(1):74-84.
  • 8lonescu M,Stroescu C,Ciurea S,et al. The value of resection in pancreatic cancer:the analysis of an experience of 180 patients in 10 years[J]. Chirurgia(Bucur),2004.99(4):211-220.
  • 9Granados-Soto V. Pleiotropic effects of resveratrol[J]. Drug News Perspect, 2003,16(5):299-307.
  • 10吴军正,司徒镇强,刘志斌,陈建元,李峰,刘斌,李焰,阎晓光.涎腺粘液表皮样癌高转移细胞克隆的筛选及其生物学特性[J].第四军医大学学报,1998,19(1):1-4. 被引量:28

共引文献6

同被引文献44

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部